Ikeda Shiyo, Takahashi Toshiya, Tandoh Toshitsugu, Ushiyama Kaori, Kida Yujiro
Department of Nephrology, Takashimadaira Chūō General Hospital, Japan.
Blood Purification Center, Takashimadaira Chūō General Hospital, Japan.
Intern Med. 2024;63(5):649-657. doi: 10.2169/internalmedicine.2091-23.
A 90-year-old man on maintenance hemodialysis was admitted due to severe symptomatic anemia. Biopsies under esophagogastroduodenoscopy demonstrated that the cause of anemia was intermittent blood oozing from multiple gastric hyperplastic polyps. Even after successful eradication of Helicobacter pylori, he showed hypergastrinemia (480 pg/mL) owing to esomeprazole (proton-pump inhibitor) therapy for the past 4.5 years to treat reflux esophagitis. Seven months after we switched esomeprazole to famotidine (H-receptor antagonist), those gastric polyps and anemia were remarkably ameliorated with lowered gastrin levels. This case indicates that long-term use of a proton-pump inhibitor triggers chronic hypergastrinemia, leading to gastric hyperplastic polyps and subsequent severe anemia.
一名维持性血液透析的90岁男性因严重的症状性贫血入院。食管胃十二指肠镜检查活检显示,贫血的原因是多个胃增生性息肉间歇性渗血。即使成功根除幽门螺杆菌后,由于过去4.5年使用埃索美拉唑(质子泵抑制剂)治疗反流性食管炎,他仍表现为高胃泌素血症(480 pg/mL)。在我们将埃索美拉唑换为法莫替丁(H受体拮抗剂)7个月后,那些胃息肉和贫血症状明显改善,胃泌素水平降低。该病例表明,长期使用质子泵抑制剂会引发慢性高胃泌素血症,导致胃增生性息肉及随后的严重贫血。